Romiplostim Treatment of Chemotherapy-Induced Thrombocytopenia

PURPOSE: Chemotherapy-induced thrombocytopenia (CIT) leads to delay or reduction in cancer treatment. There is no approved treatment. METHODS: We conducted a phase II randomized trial of romiplostim versus untreated observation in patients with solid tumors with CIT. Before enrollment, patients had...

Descripción completa

Detalles Bibliográficos
Autores principales: Soff, Gerald A., Miao, Yimei, Bendheim, Gemma, Batista, Jeanette, Mones, Jodi V., Parameswaran, Rekha, Wilkins, Cy R., Devlin, Sean M., Abou-Alfa, Ghassan K., Cercek, Andrea, Kemeny, Nancy E., Sarasohn, Debra M., Mantha, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2019
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823892/
https://www.ncbi.nlm.nih.gov/pubmed/31545663
http://dx.doi.org/10.1200/JCO.18.01931

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823892/
https://www.ncbi.nlm.nih.gov/pubmed/31545663
http://dx.doi.org/10.1200/JCO.18.01931

Ejemplares similares